<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, 90% of clots are located in the left atrial appendage (LAA) </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, LAA exclusion is a means of preventing <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and subsequent <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in these patients </plain></SENT>
<SENT sid="2" pm="."><plain>The LAA can be excluded from the systemic circulation via surgical, percutaneous, or thoracoscopic approaches </plain></SENT>
<SENT sid="3" pm="."><plain>The surgical aim is complete obliteration of the appendage without a significant increase in either postoperative complications (<z:mp ids='MP_0001914'>bleeding</z:mp>, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>) or recurrence </plain></SENT>
<SENT sid="4" pm="."><plain>We discuss the current surgical techniques available for LAA obliteration and review their results. doi: 10.1111/jocs.12055 (J Card Surg 2013;28:199-206) </plain></SENT>
</text></document>